Search research articles
Contact Us
Filters
Showing results (21-30 of 131) with videos related to
Page
of 14
Sort By:
American Journal of Physiology. Renal Physiology
|
September 4, 2009
Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation
Christoph Daniel, Andrea Wagner, Bernd Hohenstein, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 24, 2018
Assessment of In Vivo Kidney Cell Death: Acute Kidney Injury
Wulf Tonnus, Moath Al-Mekhlafi, Christian Hugo, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 6, 2004
The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1
Christoph Daniel, Jeffrey Pippin, Stuart J Shankland, et al.
Atherosclerosis. Supplements
|
May 5, 2015
Treatment of antibody-mediated rejection including immunoadsorption during first year after renal transplantation--Clinical results and regulation of endothelial progenitor cells
Mirian Opgenoorth, Andrea Wagner, Jens Passauer, et al.
Transplantation
|
December 20, 2007
The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat
Regina Vogelbacher, Sandra Wittmann, Andrea Braun, et al.
Diabetes
|
September 20, 2007
Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo
Christoph Daniel, Kathrin Schaub, Kerstin Amann, et al.
Journal of the American Society of Nephrology : JASN
|
February 9, 2007
Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in experimental glomerulonephritis in mice
Christoph Daniel, Kerstin Amann, Bernd Hohenstein, et al.
Cell Chemical Biology
|
April 18, 2020
Ferroptosis and Necroptosis in the Kidney
Alexia Belavgeni, Claudia Meyer, Julian Stumpf, et al.
Plos One
|
December 31, 2013
Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy
Christoph Daniel, Regina Vogelbacher, Andrea Stief, et al.
American Journal of Physiology. Renal Physiology
|
November 25, 2004
Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis
Bernd Hohenstein, Christoph Daniel, Andrea Wagner, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 131) with videos related to
Sort By:
Page
of 14
American Journal of Physiology. Renal Physiology
|
September 4, 2009
Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation
Christoph Daniel, Andrea Wagner, Bernd Hohenstein, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 24, 2018
Assessment of In Vivo Kidney Cell Death: Acute Kidney Injury
Wulf Tonnus, Moath Al-Mekhlafi, Christian Hugo, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 6, 2004
The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1
Christoph Daniel, Jeffrey Pippin, Stuart J Shankland, et al.
Atherosclerosis. Supplements
|
May 5, 2015
Treatment of antibody-mediated rejection including immunoadsorption during first year after renal transplantation--Clinical results and regulation of endothelial progenitor cells
Mirian Opgenoorth, Andrea Wagner, Jens Passauer, et al.
Transplantation
|
December 20, 2007
The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat
Regina Vogelbacher, Sandra Wittmann, Andrea Braun, et al.
Diabetes
|
September 20, 2007
Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo
Christoph Daniel, Kathrin Schaub, Kerstin Amann, et al.
Journal of the American Society of Nephrology : JASN
|
February 9, 2007
Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in experimental glomerulonephritis in mice
Christoph Daniel, Kerstin Amann, Bernd Hohenstein, et al.
Cell Chemical Biology
|
April 18, 2020
Ferroptosis and Necroptosis in the Kidney
Alexia Belavgeni, Claudia Meyer, Julian Stumpf, et al.
Plos One
|
December 31, 2013
Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy
Christoph Daniel, Regina Vogelbacher, Andrea Stief, et al.
American Journal of Physiology. Renal Physiology
|
November 25, 2004
Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis
Bernd Hohenstein, Christoph Daniel, Andrea Wagner, et al.
Page
of 14